XIth Eurasian Hematology-Oncology Congress - EHOC 2020


 

Decision Making in R/R MM: What Options to Consider for 1st Relapse in Disease not Refractory to Lenalidomide, First Relapse in Lenalidomide-Refractory Disease, or After 2+ Prior Therapies?

36 views
January 11, 2021
0 Comments
Login to view comments. Click here to Login